Skip to main content
Log in

Was gibt’s Neues beim Harnblasenkarzinom*

  • AUO
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Jocham D, Witjes F, Wagner S et al. (2005) Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 174: 862–866

    Article  PubMed  Google Scholar 

  2. de Reijke TM, Kurth KH, Sylvester RJ et al. (2005) Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906). J Urol 173: 405–409

    Article  PubMed  Google Scholar 

  3. Kipp BR, Karnes RJ, Brankley SM et al. (2005) Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization. J Urol 173: 401–404

    Article  PubMed  Google Scholar 

  4. Dyrskjot L, Zieger K, Kruhoffer M et al. (2005) A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 11: 4029–4036

    Article  PubMed  Google Scholar 

  5. Blaveri E, Simko JP, Korkola JE et al. (2005) Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Re 11: 4044–4055

    Article  Google Scholar 

  6. Harisinghani MG, Barentsz J, Hahn PF et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 19:348: 2491–2499

    Article  Google Scholar 

  7. Deserno WM, Harisinghani MG, Taupitz M et al. (2004) Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233: 449–456

    PubMed  Google Scholar 

  8. Fleischmann A, Thalmann GN, Markwalder R, Studer UE (2005) Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 23: 2358–2365

    Article  PubMed  Google Scholar 

  9. Kurahashi T, Hara I, Oka N et al. (2005) Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 11: 3773–3777

    Article  PubMed  Google Scholar 

  10. Retz MM, Sidhu SS, Blaveri E et al. (2005) CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer 114: 182–189

    Article  PubMed  Google Scholar 

  11. Retz M, Sidhu SS, Lehmann J et al. (2005) New HIV-drug inhibits in vitro bladder cancer migration and invasion. Eur Urol 48: 1025–1030

    Article  PubMed  Google Scholar 

  12. Advanced Bladder Cancer (ABC) meta-analysis collaboration (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48: 202–205

    Article  PubMed  Google Scholar 

  13. Advanced Bladder Cancer (ABC) meta-analysis collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 48: 189–199

    Article  PubMed  Google Scholar 

  14. Lehmann J, Retz M, Wiemers C et al. (2005) Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol 23: 4963–4974

    Article  PubMed  Google Scholar 

  15. Gschwend JE, Volkmer BG, Hautmann RE (2004) Radical cystectomy for bladder cancer in the neobladder era – progression and survival in 674 consecutive patients. J Urol 171: 304A

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jürgen Gschwend.

Additional information

* Präsentation im Rahmen des Schlussforums der Jahrestagung der Deutschen Gesellschaft für Urologie, Düsseldorf 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gschwend, J. Was gibt’s Neues beim Harnblasenkarzinom*. Urologe 45, 496–498 (2006). https://doi.org/10.1007/s00120-006-1040-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-006-1040-8

Navigation